ArticleMolecular cancer research : MCR2025
Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors.
Leslie Cuellar-Vite et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it